| Literature DB >> 28894269 |
Palani Sharmiladevi1, Viswanathan Haribabu1, Koyeli Girigoswami1, Abubacker Sulaiman Farook2, Agnishwar Girigoswami3.
Abstract
In the present work, an attempt was made to engineer a mesoporous silica coated magnetic nanoparticles (MNF@mSiO2) for twin mode contrast in magnetic resonance imaging (MRI) with reduced toxicity. Superparamagnetic manganese ferrite nanoparticles were synthesized with variable mesoporous silica shell thickness to control the water molecules interacting with metal oxide core. 178 nm was the optimum hydrodynamic diameter of mesoporous ferrite core-shell nanoparticles that showed maximum longitudinal relaxation time (T1) and transverse relaxation time (T2) in MRI due to the storage of water molecules in mesoporous silica coating. Besides the major role of mesoporous silica in controlling relaxivity, mesoporous silica shell also reduces the toxicity and enhances the bioavailability of superparamagnetic manganese ferrite nanoparticles. The in vitro toxicity assessment using HepG2 liver carcinoma cells shows that the mesoporous silica coating over ferrite nanoparticles could exert less toxicity compared to the uncoated particle.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28894269 PMCID: PMC5593907 DOI: 10.1038/s41598-017-11710-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(A) X-ray diffraction pattern of synthesized MNF using Co-precipitation method. (B) Hysteresis loop of MNF at room temperature for the assessment of superparamagnetism. (C) FTIR spectra of MNF & MNF@mSiO2. (D) FESEM image of mesoporous silica coated nanoparticles (S3).
Figure 2(A) Spectral representation of hydrodynamic diameter of colloidal MNF and different MNF@mSiO2. Inset shows variations in hydrodynamic diameter with increasing concentrations of TEOS. (B) Absorption spectra of colloidal MNF and MNF@mSiO2.
Plasmon band for MNF@mSiO2 for variable TEOS concentration.
| @Si gm | Plasmon band (nm) | Intensity (a.u.) |
|---|---|---|
| MNF | 428 | 0.28 |
| S1 | 389 | 0.50 |
| S2 | 386 | 0.62 |
| S3 | 380 | 0.66 |
| S4 | 390 | 0.44 |
| S6 | 406 | 0.26 |
Figure 3MR phantom images for different MNF@mSiO2. (A) T1 weighted and (B) T2 weighted MRI.
Tabulated intensities obtained from T1 and T2 weighted phantom MR images.
| Particles | T1 Intensity (a.u.) | T2 Intensity (a.u.) |
|---|---|---|
| MNF | 81 | 178 |
| S2 | 89 | 91 |
|
|
|
|
| S4 | 168 | 81 |
| S5 | 137 | 122 |
| S6 | 97 | 177 |
Figure 4(A) Exponential growth curve for T1 signal intensity with increasing Echo Time. (B) Exponential decay curve for T2 signal intensity with increasing Echo Time.
Figure 5Graphical representation of percent cell viability obtained from MTT assay using HepG2 liver carcinoma cells.